Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
Milewicz T, Kostecka A, Rogatko I, Sztefko K, Kwiatkowska-Panek E, Radowick S, Krzysiek J. Milewicz T, et al. Among authors: sztefko k. Przegl Lek. 2007;64(2):65-9. Przegl Lek. 2007. PMID: 17892034 Clinical Trial. Polish.
The impact of progesterone on simultaneous, local secretion of IGFBP-3 and IGF-I [IGFBP-3/IGF-I index] by human malignant and non-malignant breast explants depends on tissue steroid receptor phenotype.
Krzysiek J, Milewicz T, Augustowska K, Sztefko K, Ryś J, Zubel A, Pityński K, Jaszczyński P, Herman K, Basta A, Stachura J, Gregoraszczuk EŁ. Krzysiek J, et al. Among authors: sztefko k. Ginekol Pol. 2003 Sep;74(9):767-74. Ginekol Pol. 2003. PMID: 14674122
Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
Milewicz T, Gregoraszczuk EL, Sztefko K, Augustowska K, Krzysiek J, Ryś J. Milewicz T, et al. Among authors: sztefko k. Growth Horm IGF Res. 2005 Apr;15(2):140-7. doi: 10.1016/j.ghir.2004.12.006. Growth Horm IGF Res. 2005. PMID: 15809018
Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T, Kolodziejczyk J, Krzysiek J, Basta A, Sztefko K, Kurek S, Stachura J, Gregoraszczuk EL. Milewicz T, et al. Among authors: sztefko k. Gynecol Endocrinol. 2002 Aug;16(4):319-29. Gynecol Endocrinol. 2002. PMID: 12396561
133 results